The Myeloma Investment Fund® (MIF) invests in companies developing innovative therapies and technologies that have the potential to transform outcomes for myeloma patients.
We are a private lending institution group of German businessmen who invest in companies developing innovative therapies and technologies in several areas:
Development: From residential to commercial, we can help you bring your vision to life.
* **Acquisition: Need financing to secure a valuable asset? We can provide the necessary capital.
* **Financing:** Obtain the funds you need for your ongoing operations and expansion.
* **Equity Investment: Partner with us to fuel your growth and unlock new opportunities.
* **Hotels and Multifamily:** We have experience investing in profitable real estate projects. * **Infrastructure:** Contribute to the development of critical infrastructure projects.
* **Corporate Financing: Access the capital your business needs to thrive.
* **Energy:** Invest in sustainable energy solutions and the automotive industry.
* **Other Viable Projects:** We are open to exploring new opportunities. We offer financing from €200,000 ($) to €900 million ($) at an interest rate of 2% for anyone capable of repaying it.
Contact us now:
jurgenmarkos@gmail.com
Leave feedback about this